Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells-Reference-Cited by-同舟云学术

Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells

Published:2006-07-05 Issue:0 Volume:0 Page:060705083413015-???
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Jacob Dietmar A,Bahra Marcus,Langrehr Jan M,Boas-Knoop Sabine,Stefaniak Robert,Davis John,Schumacher Guido,Lippert Steffen,Neumann Ulf P

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2006.04496.x/fullpdf

Reference32 articles.

1. Role of Gemcitabine in the Treatment of Advanced and Metastatic Breast Cancer

2. Gemcitabine-based combination treatment of pancreatic cancer

3. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

4. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

5. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation;Biomarker Research;2024-05-04

2. Combining Poly (ADP-Ribose) Polymerase (PARP) Inhibitors with Chemotherapeutic Agents: Promise and Challenges;Targeting the DNA Damage Response for Cancer Therapy;2023

3. Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers;Biomedicines;2021-08-16

4. A preliminary study on the synthetic lethal effect of berberine and olaparib on pancreatic cancer cells and its mechanism;E3S Web of Conferences;2021

5. Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy;ChemMedChem;2020-09-10